{"disease":{"id":"overactive-bladder-oab","name":"overactive bladder oab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03903094","title":"A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden","phase":"","overall_status":"COMPLETED","enrollment_count":6295279,"lead_sponsor_name":"Astellas Pharma Singapore Pte. Ltd.","has_results":false},{"nct_id":"NCT03602508","title":"Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania","phase":"","overall_status":"COMPLETED","enrollment_count":5589,"lead_sponsor_name":"Astellas Pharma Singapore Pte. Ltd.","has_results":false},{"nct_id":"NCT01936870","title":"Drug Use Investigation for Toviaz","phase":"","overall_status":"COMPLETED","enrollment_count":2521,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07371000","title":"Early Detection of OAB and Elimination of Negative Impact on Quality of Life","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute of Health Information and Statistics of the Czech Republic","has_results":false},{"nct_id":"NCT02216214","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":888,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT03572231","title":"A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China","phase":"","overall_status":"COMPLETED","enrollment_count":805,"lead_sponsor_name":"Astellas Pharma Singapore Pte. Ltd.","has_results":false},{"nct_id":"NCT02294396","title":"Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":649,"lead_sponsor_name":"Astellas Pharma Inc","has_results":true},{"nct_id":"NCT02138747","title":"A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT03596671","title":"BlueWind RENOVA iStim™ System for the Treatment of OAB","phase":"NA","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"BlueWind Medical","has_results":true},{"nct_id":"NCT04562090","title":"A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Astellas Pharma China, Inc.","has_results":true},{"nct_id":"NCT07209397","title":"Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women","phase":"NA","overall_status":"RECRUITING","enrollment_count":202,"lead_sponsor_name":"InMode MD Ltd.","has_results":false},{"nct_id":"NCT06765629","title":"Transcutaneous Tibial Nerve Stimulation Therapy in Children With Overactive Bladder","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05702294","title":"Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .","phase":"NA","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Birmingham Women's and Children's NHS Foundation Trust","has_results":false},{"nct_id":"NCT06953271","title":"Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":164,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT07195656","title":"Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)","phase":"NA","overall_status":"RECRUITING","enrollment_count":151,"lead_sponsor_name":"FemPulse Corporation","has_results":false},{"nct_id":"NCT07081906","title":"Transdermal Versus Oral Oxybutynin in Pediatric OAB","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Dr. Lutfi Kirdar Kartal Training and Research Hospital","has_results":false},{"nct_id":"NCT06783374","title":"Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence","phase":"NA","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Fundación Universidad Católica de Valencia San Vicente Mártir","has_results":false},{"nct_id":"NCT07025642","title":"Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Mackay Medical College","has_results":false},{"nct_id":"NCT07391878","title":"Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Trigone Pharma Ltd.","has_results":false},{"nct_id":"NCT07081412","title":"Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT03846895","title":"Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB)","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT06209333","title":"Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT07279142","title":"Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT07206446","title":"A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"University of Galway","has_results":false},{"nct_id":"NCT04914221","title":"The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05211193","title":"Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Stimvia s.r.o.","has_results":false},{"nct_id":"NCT06785558","title":"The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children With Overactive Bladder","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Marmara University","has_results":false},{"nct_id":"NCT07025044","title":"Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Alexis Dieter","has_results":false},{"nct_id":"NCT06944392","title":"Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06780163","title":"Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT04641975","title":"A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT06885099","title":"Ease of Use Study of the FemPulse System","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"FemPulse Corporation","has_results":false},{"nct_id":"NCT07193407","title":"INOPASE - Performance and Safety Study of a Personalised SNM System","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"INOPASE Pty Ltd","has_results":false},{"nct_id":"NCT01317810","title":"A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false}],"total":34},"guidelines":[],"source":"Drug Landscape verified database"}